DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications

Title
DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications
Authors
Keywords
DYRK1A, Dual-specificity kinases, Kinase inhibitors, Down syndrome, Alzheimer’s disease, Cancer
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 151, Issue -, Pages 87-98
Publisher
Elsevier BV
Online
2015-03-23
DOI
10.1016/j.pharmthera.2015.03.004

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started